Back to Stacks
Weight Loss & Metabolic Health

The Metabolic Shred (Tirzepatide + AOD-9604)

Combines systemic metabolic reset with targeted fat mobilization.

Duration & Cycling3 to 6 Months
Components2 Peptides
Protocol Components

Protocol Components

Duration & Cycling: 3 to 6 Months
Once Weekly

Inject Tirzepatide (Standard Titration)

Systemic metabolic base.
Daily (AM)

Inject AOD-9604 (300-500mcg)

Fasted state. Promotes fat mobilization for the day.

Mechanism of Action

This stack addresses obesity via two distinct physiological mechanisms: Central Metabolic Control and Direct Lipolysis. 1. Tirzepatide (The Controller): Acts on the brain and pancreas. It signals satiety to the hypothalamus (reducing calorie intake) and optimizes insulin secretion. However, while it creates a calorie deficit, it does not specifically instruct the body *where* to take energy from. 2. AOD-9604 (The Mobilizer): A fragment of Human Growth Hormone that binds to Beta-3 Adrenergic receptors on fat cells. It specifically triggers lipolysis (fat breakdown) and inhibits lipogenesis (fat storage), particularly in stubborn visceral areas, without affecting blood sugar. Synergy: By adding AOD-9604 to Tirzepatide, you create a 'directed' weight loss environment. Tirzepatide ensures the caloric deficit exists (Input Control), while AOD-9604 ensures that the energy gap is filled by burning stored body fat rather than lean muscle tissue (Output Optimization). This is theorized to prevent the 'skinny fat' look sometimes associated with rapid weight loss.

References

Used For

Rapid Fat Loss
Preservation of Lean Muscle
Targeted Visceral Fat Reduction
Insulin Sensitivity

Important Notes

Nausea

Mainly from Tirzepatide; AOD does not typically add nausea.

Research Use OnlyThis information is for educational and research purposes only. Always consult properly licensed professionals.